{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:12:53Z","timestamp":1783930373450,"version":"3.55.0"},"reference-count":45,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Early diagnosis of acute myocardial infarction (AMI) remains challenging due to the \u201cdiagnostic blind window\u201d of conventional protein biomarkers and the limited sensitivity of electrocardiograms in non ST-segment elevation myocardial infarction (NSTEMI). Cardiospecific circulating microRNAs, specifically the microRNA-208 (miR-208) family, have emerged as promising candidates to bridge this gap. This systematic review and meta-analysis evaluated the diagnostic accuracy of circulating miR-208 and outlines a proposed conceptual framework to guide its clinical translation. Materials and Methods: PubMed and Embase were systematically searched up to June 24th, 2026, for clinical studies evaluating the diagnostic performance of circulating miR-208a and\/or miR-208b against standard reference definitions for AMI. Risk-of-bias assessment using the QUADAS-2 tool was performed independently by two reviewers. Pooled sensitivity and specificity were estimated using bivariate random effects modeling, and sources of heterogeneity were explored via subgroup analyses. Results: Forty-one studies enrolling 6306 participants were included in the qualitative synthesis, of which 14 were eligible for meta-analysis. The pooled sensitivity and specificity of circulating miR-208 for AMI detection were 0.89 (95% CI: 0.81\u20130.94) and 0.90 (95% CI: 0.83\u20130.94), respectively. Marked between-study heterogeneity was observed. Subgroup analyses revealed significantly higher diagnostic accuracy in isolated STEMI (sensitivity: 0.95) or NSTEMI (sensitivity: 0.93) cohorts compared to mixed chest pain populations (sensitivity: 0.65; p &lt; 0.0001). Specificity dropped from 0.90 with healthy controls to 0.80 when using non-AMI controls (p = 0.002), indicating spectrum bias. Funnel plots suggested prominent small-study effects. Conclusions: Circulating miR-208 exhibits a powerful biological signal for the early detection of cardiomyocyte injury, but its standalone clinical utility is constrained by methodological heterogeneity and publication bias. Rather than an immediate clinical tool, future prospective translation requires evaluating this biomarker within the standardized miAMI framework\u2014conceptually prioritizing future investigation of the hyper-acute (&lt;2 h) window, absolute quantification to resolve normalization variability, and integration into multi-marker point-of-care panels.<\/jats:p>","DOI":"10.3390\/medicina62071351","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T07:28:27Z","timestamp":1783927707000},"page":"1351","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bridging the Troponin Blind Window via the miAMI Standard: A Systematic Review and Meta-Analysis of the Circulating MicroRNA-208 Family"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8358-9294","authenticated-orcid":false,"given":"Augustin","family":"Crabbe","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8365-0487","authenticated-orcid":false,"given":"Andreea Laura","family":"Antohi","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5551-6077","authenticated-orcid":false,"given":"Gianina","family":"Dodi","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9985-2486","authenticated-orcid":false,"given":"Adrian","family":"Covic","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3250-2780","authenticated-orcid":false,"given":"Samar","family":"Abd ElHafeez","sequence":"additional","affiliation":[{"name":"Epidemiology Department, High Institute of Public Health, Alexandria University, Alexandria 21526, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2882-4226","authenticated-orcid":false,"given":"Francesco","family":"Pesce","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Surgery, Universita Cattolica del Sacro Cuore, 00168 Rome, Italy"},{"name":"Division of Renal Medicine, Ospedale Isola Tiberina-Gemelli Isola, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ionut","family":"Nistor","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2025, July 15). Cardiovascular Diseases (CVDs). Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds)."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1038\/s41591-020-1059-1","article-title":"Global maps of travel time to healthcare facilities","volume":"26","author":"Weiss","year":"2020","journal-title":"Nat. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e012810","DOI":"10.1161\/CIRCINTERVENTIONS.122.012810","article-title":"Reperfusion delays and outcomes among patients with ST-segment\u2013elevation myocardial infarction with and without cardiogenic shock","volume":"16","author":"Kochan","year":"2023","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_4","first-page":"55","article-title":"2023 ESC guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC)","volume":"13","author":"Byrne","year":"2024","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/VHRM.S166157","article-title":"Biomarkers in acute myocardial infarction: Current perspectives","volume":"15","author":"Aydin","year":"2019","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jjcc.2022.07.003","article-title":"Treatment strategies of acute myocardial infarction: Updates on revascularization, pharmacological therapy, and beyond","volume":"81","author":"Saito","year":"2023","journal-title":"J. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1161\/CIRCULATIONAHA.121.058489","article-title":"Skeletal muscle disorders: A noncardiac source of cardiac troponin T","volume":"145","author":"Prepoudis","year":"2022","journal-title":"Circulation"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth Universal Definition of Myocardial Infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1093\/ckj\/sfaa215","article-title":"High-sensitivity troponins in dialysis patients: Variation and prognostic value","volume":"14","author":"Snaedal","year":"2021","journal-title":"Clin. Kidney J."},{"key":"ref_10","first-page":"175","article-title":"Extracellular\/circulating microRNAs: Release mechanisms, functions and challenges","volume":"10","author":"Sohel","year":"2016","journal-title":"Achiev. Life Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/CIRCRESAHA.111.247452","article-title":"Circulating microRNAs: Novel biomarkers and extracellular communicators in cardiovascular disease?","volume":"110","author":"Creemers","year":"2012","journal-title":"Circ. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1126\/science.1139089","article-title":"Control of stress-dependent cardiac growth and gene expression by a microRNA","volume":"316","author":"Sutherland","year":"2007","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"613","DOI":"10.5603\/KP.a2015.0067","article-title":"Release kinetics of circulating miRNA-208a in the early phase of myocardial infarction","volume":"73","author":"Zajkowska","year":"2015","journal-title":"Kardiol. Pol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/eurheartj\/ehq013","article-title":"Circulating microRNA: A novel potential biomarker for early diagnosis of acute myocardial infarction in humans","volume":"31","author":"Wang","year":"2010","journal-title":"Eur. Heart J."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Zhang, L., Ding, H., Zhang, Y., Wang, Y., Zhu, W., and Li, P. (2020). Circulating MicroRNAs: Biogenesis and clinical significance in acute myocardial infarction. Front. Physiol., 11.","DOI":"10.3389\/fphys.2020.01088"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Tanase, D.M., Gosav, E.M., Ouatu, A., Badescu, M.C., Dima, N., Ganceanu-Rusu, A.R., Popescu, D., Floria, M., Rezus, E., and Rezus, C. (2021). Current knowledge of MicroRNAs (miRNAs) in acute coronary syndrome (ACS): ST-elevation myocardial infarction (STEMI). Life, 11.","DOI":"10.3390\/life11101057"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1155\/2013\/217948","article-title":"Circulating microRNAs: A potential role in diagnosis and prognosis of acute myocardial infarction","volume":"35","author":"Sayed","year":"2013","journal-title":"Dis. Markers"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1373\/clinchem.2011.173823","article-title":"Use of circulating microRNAs to diagnose acute myocardial infarction","volume":"58","author":"Devaux","year":"2012","journal-title":"Clin. Chem."},{"key":"ref_19","first-page":"4442","article-title":"Rapid diagnosis of acute myocardial infarction based on reverse transcription-accelerated strand exchange amplification of miR-208a","volume":"15","author":"Zhao","year":"2023","journal-title":"Anal. Methods Adv. Methods Appl."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000328869","article-title":"Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples","volume":"118","author":"Andersson","year":"2011","journal-title":"Cardiology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"C91","DOI":"10.1016\/j.jacc.2017.07.321","article-title":"GW28-e0139 The role of plasma miR-208b-3p in the prognostic and risk stratification of acute myocardial infarction","volume":"70","author":"Zhang","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jacc.2013.05.025","article-title":"Release kinetics of circulating muscle-enriched microRNAs in patients undergoing transcoronary ablation of septal hypertrophy","volume":"62","author":"Liebetrau","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.yjmcc.2011.07.011","article-title":"Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome","volume":"51","author":"Widera","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/CIRCGENETICS.110.957415","article-title":"Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease","volume":"3","author":"Corsten","year":"2010","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/CIRCRESAHA.119.314937","article-title":"Comparative Analysis of Circulating Noncoding RNAs Versus Protein Biomarkers in the Detection of Myocardial Injury","volume":"125","author":"Schulte","year":"2019","journal-title":"Circ. Res."},{"key":"ref_26","first-page":"26","article-title":"Expressions of miR-132, miR-145 and miR-208 in Patients with Acute Myocardial Infarction and Correlations with Gensini Score","volume":"23","author":"Lin","year":"2023","journal-title":"Int. J. Hum. Genet."},{"key":"ref_27","first-page":"7030722","article-title":"Diagnostic and Prognostic Significance of microRNA-208a in Acute Myocardial Infarction","volume":"2022","author":"Chen","year":"2022","journal-title":"Dis. Markers"},{"key":"ref_28","first-page":"627","article-title":"In acute myocardial infarction and stable coronary heart disease","volume":"61","author":"Kula","year":"2013","journal-title":"Minerva Cardioangiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e2201330","DOI":"10.1002\/smll.202201330","article-title":"Human Heart Anoxia and Reperfusion Tissue (HEART) Model for the Rapid Study of Exosome Bound miRNA Expression As Biomarkers for Myocardial Infarction","volume":"18","author":"Ellis","year":"2022","journal-title":"Small"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.1111\/jcmm.14463","article-title":"MiR-1, miR-499 and miR-208 are sensitive markers to diagnose sudden death due to early acute myocardial infarction","volume":"23","author":"Pinchi","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Kakimoto, Y., Kamiguchi, H., Ochiai, E., Satoh, F., and Osawa, M. (2015). MicroRNA Stability in Postmortem FFPE Tissues: Quantitative Analysis Using Autoptic Samples from Acute Myocardial Infarction Patients. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0129338"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000268088","article-title":"MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction","volume":"115","author":"Zidar","year":"2010","journal-title":"Cardiology"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Crouser, E.D., Julian, M.W., Bicer, S., Ghai, V., Kim, T.-K., Maier, L.A., Gillespie, M., Hamzeh, N.Y., and Wang, K. (2021). Circulating exosomal microRNA expression patterns distinguish cardiac sarcoidosis from myocardial ischemia. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0246083"},{"key":"ref_34","first-page":"881","article-title":"Circulating miR-208b and miR-499 as potential and emerging biomarkers for diagnosis of Acute Myocardial Infarction","volume":"26","author":"Agiannitopoulos","year":"2018","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_35","first-page":"197","article-title":"Application Value of Combined Detection of miR-208 and miR-92a in Early Diagnosis of Myocardial Infarction","volume":"30","author":"Zhi","year":"2024","journal-title":"Altern. Ther. Health Med."},{"key":"ref_36","first-page":"313","article-title":"Expression of miR-208b and miR-499 in Greek Patients with Acute Myocardial Infarction","volume":"32","author":"Agiannitopoulos","year":"2018","journal-title":"In Vivo"},{"key":"ref_37","first-page":"713","article-title":"Diagnostic and Prognostic Role of Micro RNA 208 in Patients Undergoing Primary Percutaneous Coronary Intervention","volume":"11","author":"Baraka","year":"2020","journal-title":"Indian J. Public Health Res. Dev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s12010-021-03695-6","article-title":"Copeptin, miRNA-208, and miRNA-499 as New Biomarkers for Early Detection of Acute Coronary Syndrome","volume":"194","author":"Gaber","year":"2022","journal-title":"Appl. Biochem. Biotechnol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40001-015-0148-y","article-title":"Clinical impact of circulating miR-26a, miR-191, and miR-208b in plasma of patients with acute myocardial infarction","volume":"20","author":"Li","year":"2015","journal-title":"Eur. J. Med. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/joim.12183","article-title":"Diagnostic and prognostic value of circulating microRNAs in patients with acute chest pain","volume":"277","author":"Devaux","year":"2013","journal-title":"J. Intern. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.exger.2015.10.011","article-title":"Plasma miR-1, miR-208, miR-499 as potential predictive biomarkers for acute myocardial infarction: An independent study of Han population","volume":"72","author":"Liu","year":"2015","journal-title":"Exp. Gerontol."},{"key":"ref_42","first-page":"848","article-title":"A meta-analysis of the relations between blood microRNA-208b detection and acute myocardial infarction","volume":"21","author":"Zhang","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"C94","DOI":"10.1016\/j.jacc.2016.07.352","article-title":"GW27-e0556 Clinical impact of circulating miR-208b, miR-499 and miR-378 in acute myocardial infarction","volume":"68","author":"Xia","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1007\/s12265-020-10020-9","article-title":"MicroRNA-208a: A Good Diagnostic Marker and a Predictor of no-Reflow in STEMI Patients Undergoing Primary Percutaneuos Coronary Intervention","volume":"13","author":"Salama","year":"2020","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Gidl\u00f6f, O., Smith, J.G., Miyazu, K., Gilje, P., Spencer, A., Blomquist, S., and Erlinge, D. (2013). Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction. BMC Cardiovasc. Disord., 13.","DOI":"10.1186\/1471-2261-13-12"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/7\/1351\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T07:57:49Z","timestamp":1783929469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/7\/1351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":45,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["medicina62071351"],"URL":"https:\/\/doi.org\/10.3390\/medicina62071351","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]}}}